• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Thursday 07/19/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

cash dividend

  • 3:06 PM

    PADUCAH, Ky., March 2, 2016 /PRNewswire/ — Computer Services, Inc. (CSI) (OTCQX: CSVI) announced that its Board of Directors declared a quarterly cash dividend of $0.25 per share. The dividend is payable on March 31, 2016, to shareholders of record as of the close of business on March 15, 2016. The quarterly dividend represents an indicated annual dividend rate of $1.00 per share. “This quarter’s cash dividend represents a 13.6% increase compared with the $0.22 per share amount paid last

    Read more
  • SilverSun Technologies
    3:39 PM

    LIVINGSTON, N.J., Jan. 11, 2016, SSNT, (GLOBE NEWSWIRE) — SilverSun Technologies, Inc. (OTCBB:SSNT), a national provider of transformational business technology solutions and services, today announced that its Board of Directors has declared a special cash dividend on the Company’s common stock of $0.06 per share. The record date will be January 15, 2016, and the payment date will be January 20, 2016. “We believe this special one-time cash dividend–the first in our Company’s history–is an appropriate way to reward our

    Read more
  • 2:27 PM

    – Funding to support GMP manufacture of VesiculoVax(TM)-vectored vaccines for Zaire-Ebola virus, Sudan-Ebola virus, and Angola-Marburg virus that will be blended into a single formulation; rapid follow-up Phase 1 clinical trial planned — Phase 1 clinical trial of VesiculoVax(TM) Zaire-Ebola virus vaccine funded –BALTIMORE, Md., Oct. 31, 2014 /PRNewswire via COMTEX/ — Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense (DoD) through the Medical

    Read more
  • 4:54 PM

    http://www.publicwire.com EL PASO, Texas, Apr 02, 2014 (BUSINESS WIRE) — Premier Biomedical, Inc. (OTCBB:BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies, has prepared and will file a provisional patent application for an anti-breast cancer treatment methodology protocol, in conjunction with its partners in R&D at the Department of Defense (DOD) with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP) covering its study accepted for

    Read more
Public Wire Banner